Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus morphine + Apotel for pain control in acute myocardial infarction
IRCT20220119053760N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in myocardial infarction (MI) comparing Morphine alone with Morphine + Apotel (2 arms). Primary endpoints: Pain intensity, Systolic blood pressure and 5 more. Started Jan 2019; status: completed.
02
Drugs
morphineacetaminophen
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20220119053760N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220119053760N1.